DEPARTMENT OF DEFENSE - CONGRESSIONALLY DIRECTED MEDICAL RESEARCH PROGRAMS

Synopsis of Open Program Funding Opportunities




FY21 Autism Research Program (ARP)

Mechanism Program Announcement/Instructions Release Date Funding Amount Submission Deadline
Clinical Trial Award Program Announcement
Application Instructions
March 19, 2021
  • The maximum period of performance is 4 years.
  • The maximum allowable funding for the entire period of performance is $1,800,000 in direct costs (plus indirect costs).

Early-Career Investigator Partnering PI Option:

  • The maximum period of performance is 4 years.
  • The maximum allowable funding for the entire period of performance is $2,100,000 for direct costs (plus indirect costs).
Pre-Application:
May 3, 2021

Invitation to Submit an Application:
June 2021

Application:
August 5, 2021
Idea Development Award Program Announcement
Application Instructions
March 19, 2021
  • The maximum period of performance is 3 years.
  • The maximum allowable funding for the entire period of performance is $550,000 in direct costs (plus indirect costs).
  • For multiple PIs, the combined funding for all PIs for the entire period of performance may not exceed $550,000 in direct costs (plus indirect costs).
Pre-Application:
May 3, 2021

Invitation to Submit an Application:
June 2021

Application:
August 5, 2021
Clinical Translational Research Award Program Announcement
Application Instructions
March 19, 2021
  • The maximum period of performance is 3 years.
  • The maximum allowable funding for the entire period of performance is $600,000 in direct costs (plus indirect costs).
Pre-Application:
May 3, 2021

Invitation to Submit an Application:
June 2021

Application:
August 5, 2021
Career Development Award Program Announcement
Application Instructions
March 19, 2021
  • The maximum period of performance is 3 years.
  • The maximum allowable funding for the entire period of performance is $500,000 in direct costs (plus indirect costs).
Pre-Application:
May 3, 2021

Invitation to Submit an Application:
June 2021

Application:
August 5, 2021







ERP

FY21 Epilepsy Research Program (ERP)

Mechanism Program Announcement/Instructions Release Date Funding Amount Submission Deadline
Idea Development Award Program Announcement
Application Instructions
April 13, 2021 Level I:
  • Maximum funding of $300,000 for direct costs (plus indirect costs).
  • Maximum period of performance is 3 years.
  • Indirect costs may be proposed in accordance with the institution’s rate agreement.
Level II:
  • Maximum funding of $500,000 for direct costs (plus indirect costs).
  • Maximum period of performance is 3 years.
  • Indirect costs may be proposed in accordance with the institution’s rate agreement.
Pre-Application (Letter of Intent):
June 14, 2021

Application:
July 21, 2021
Quality of Life Award Program Announcement
Application Instructions
April 13, 2021 Level I:
  • Maximum funding of $300,000 for direct costs (plus indirect costs).
  • Maximum period of performance is 3 years.
  • Indirect costs may be proposed in accordance with the institution’s rate agreement.
Level II:
  • Maximum funding of $500,000 for direct costs (plus indirect costs).
  • Maximum period of performance is 3 years.
  • Indirect costs may be proposed in accordance with the institution’s rate agreement.
Pre-Application (Letter of Intent):
June 14, 2021

Application:
July 21, 2021
Research Partnership Award Program Announcement
Application Instructions
April 13, 2021 Level I:
  • Maximum funding of $1,300,000 in total costs.
  • Maximum period of performance is 3 years.
  • Indirect costs may be proposed in accordance with the institution's rate agreement.
Level II:
  • Maximum funding of $3,100,000 in total costs.
  • Maximum period of performance is 4 years.
  • Indirect costs may be proposed in accordance with the institution's rate agreement.
Pre-Application (Letter of Intent):
June 14, 2021

Application:
July 21, 2021

GWIRP

FY21 Gulf War Illness Research Program (GWIRP)

Mechanism Program Announcement/Instructions Release Date Funding Amount Submission Deadline
Idea Award Program Announcement
Application Instructions
March 11, 2021 Maximum funding of $200,000 for direct costs (plus indirect costs).

Maximum funding of $220,000 for direct costs with the Biorepository Contribution Option (plus indirect costs).

Maximum period of performance is 2 years.

Pre-Application (Preproposal): May 7, 2021

Application: August 19, 2021
Research Advancement Award Program Announcement
Application Instructions
March 11, 2021 Maximum funding of $600,000 for direct costs (plus indirect costs).

Maximum funding of $620,000 for direct costs with the Biorepository Contribution Option (plus indirect costs).

Maximum period of performance is 3 years

Pre-Application (Preproposal): May 7, 2021

Application: August 19, 2021
Clinical Evaluation Award Program Announcement
Application Instructions
March 11, 2021 Maximum funding of $1,500,000 for direct costs (plus indirect costs).

Maximum funding of $1,520,000 for direct costs with the Biorepository Contribution Option (plus indirect costs).

Maximum funding of $1,700,000 for direct costs with the Clinical Consortium Collaboration Option (plus indirect costs).

Maximum period of performance is 3 years

Pre-Application (Preproposal): May 7, 2021

Application: August 19, 2021
Therapeutic/Biomarker Trial Award Program Announcement
Application Instructions
March 11, 2021 Maximum funding of $5,000,000 for direct costs (plus indirect costs).

Maximum funding of $5,020,000 for direct costs with the Biorepository Contribution Option (plus indirect costs).

Maximum funding of $5,500,000 for direct costs with the Clinical Consortium Collaboration Option (plus indirect costs).

Maximum period of performance is 3 years

Pre-Application (Preproposal): May 7, 2021

Application: August 19, 2021
New Investigator Award Program Announcement
Application Instructions
March 11, 2021 Maximum funding of $500,000 for direct costs (plus indirect costs).

Maximum funding of $520,000 for direct costs with the Biorepository Contribution Option (plus indirect costs).

Maximum period of performance is 3 years.

Pre-Application (Preproposal): May 7, 2021

Application: August 19, 2021

FY21 Lung Cancer Research Program (LCRP)

Mechanism Program Announcement/Instructions Release Date Funding Amount Submission Deadline
Clinical Translational Research Partnership Award Program Announcement
Application Instructions
March 1, 2021
  • Maximum combined funding of $1,200,000 for direct costs (plus indirect costs).
  • Maximum period of performance is 3 years.
Pre-Application (Letter of Intent):
July 14, 2021

Letter of Intent is required.

Application: July 28, 2021
Investigator Initiated Translational Research Award Program Announcement
Application Instructions
March 1, 2021
  • Maximum funding of $600,000 in direct costs (plus indirect costs).
  • Period of performance should not exceed 3 years.
Pre-Application (Preproposal): May 5, 2021

Preproposal is required; application submission is by invitation only.

Application: July 28, 2021
Idea Development Award Program Announcement
Application Instructions
March 8, 2021
  • Maximum funding of $350,000 in direct costs (plus indirect costs).
  • Period of performance not to exceed 2 years.
Pre-Application (Preproposal): May 5, 2021

Preproposal is required; application submission is by invitation only.

Application: July 28, 2021


FY21 Orthotics and Prosthetics Outcomes Research Program (OPORP)

Mechanism Program Announcement/Instructions Release Date Funding Amount Submission Deadline
Clinical Research Award (CRA) Program Announcement
Application Instructions
April 1, 2021

The FY21 OPORP CRA offers two funding levels:

Funding Level 1:

  • Maximum funding of $350,000 for total costs (direct costs plus indirect costs).
  • Maximum period of performance is 2 years.

Funding Level 2:

  • Maximum funding of $2,000,000 for total costs (direct costs plus indirect costs).
  • Maximum period of performance is 4 years.
Pre-Application (Letter of Intent):
July 15, 2021

Application:
July 29, 2021
Clinical Trial Award (CTA) Program Announcement
Application Instructions
April 1, 2021

The FY21 OPORP CTA offers two funding levels:

Funding Level 1:

  • Maximum funding of $350,000 for total costs (direct costs plus indirect costs).
  • Maximum period of performance is 3 years.

Funding Level 2:

  • Maximum funding of $4,000,000 for total costs (direct costs plus indirect costs).
  • Maximum period of performance is 4 years.
Pre-Application (Letter of Intent):
July 15, 2021

Application:
July 29, 2021

FY21 Ovarian Cancer Research Program (OCRP)

Mechanism Program Announcement/Instructions Release Date Funding Amount Submission Deadline
Omics Consortium Award Program Announcement
Application Instructions
March 25, 2021 Omics Development Award Option:
  • Maximum funding of $400,000 for direct costs (plus indirect costs).
  • Maximum period of performance is 2 years.

Omics Consortium Award Option:

  • Maximum funding of $2.5 million for direct costs (plus indirect costs).
  • Maximum period of performance is 4 years.
Pre-Application:
June 24, 2021

Application:
July 8, 2021


FY21 Peer Reviewed Alzheimer's Research Program (PRARP)

Mechanism Program Announcement/Instructions Release Date Funding Amount Submission Deadline
Convergence Science Research Award Program Announcement
Application Instructions
April 8, 2021 Level I:
  • Maximum funding of $225,000 for direct costs (plus indirect costs).
  • Maximum period of performance is 3 years.

Level II:

  • Maximum funding of $500,000 for direct costs (plus indirect costs).
  • Maximum period of performance is 3 years.

For Both Levels:

Indirect costs may be proposed in accordance with the institution’s rate agreement.
Pre-Application (Letter of Intent):
June 14, 2021

Application:
July 21, 2021
Innovation in Care and Support Award Program Announcement
Application Instructions
April 8, 2021 Level I:
  • Maximum funding of $225,000 for direct costs (plus indirect costs).
  • Maximum period of performance is 3 years.

Level II:

  • Maximum funding of $500,000 for direct costs (plus indirect costs).
  • Maximum period of performance is 3 years.

For Both Levels:

Indirect costs may be proposed in accordance with the institution’s rate agreement.
Pre-Application (Letter of Intent):
June 14, 2021

Application:
July 21, 2021
Research Partnership Award Program Announcement
Application Instructions
April 8, 2021
  • Funding limit is $1.3 million (M) in total costs.
  • Maximum period of performance is 3 years.
Indirect costs may be proposed in accordance with the institution’s rate agreement.
Pre-Application (Letter of Intent):
June 14, 2021

Application:
July 21, 2021
Accelerating Diagnostic Research Award Program Announcement
Application Instructions
April 8, 2021
  • Funding limit is $2.8M in total costs.
  • Maximum period of performance is 4 years.
Indirect costs may be proposed in accordance with the institution’s rate agreement.
Pre-Application (Letter of Intent):
June 14, 2021

Application:
July 21, 2021
Leveraging Approaches for Innovation in Care and Support Award Program Announcement
Application Instructions
April 8, 2021
  • Funding limit is $2.8M in total costs.
  • Maximum period of performance is 4 years.
Indirect costs may be proposed in accordance with the institution’s rate agreement.
Pre-Application (Letter of Intent):
June 14, 2021

Application:
July 21, 2021

FY21 Peer Reviewed Cancer Research Program (PRCRP)

Mechanism Program Announcement/Instructions Release Date Funding Amount Submission Deadline
Behavioral Health Science Award Program Announcement
Application Instructions
March 24, 2021
  • The maximum allowable funding for the entire period of performance is $1,000,000 for direct costs.
  • Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.
  • The maximum period of performance is 4 years.
Pre-Application (Letter of Intent):
July 29, 2021

Application: August 18, 2021
Career Development Award - Fellow Option Program Announcement
Application Instructions
March 24, 2021
  • The maximum allowable funding for the entire period of performance is $400,000 for direct costs.
  • Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.
  • The maximum period of performance is 3 years.
Pre-Application (Letter of Intent):
July 29, 2021

Application: August 18, 2021
Idea Award Program Announcement
Application Instructions
March 24, 2021
  • The maximum allowable funding for the entire period of performance is $500,000 for direct costs.
  • Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.
  • The maximum period of performance is 3 years.
Pre-Application (Preproposal):
May 20, 2021

Application:
September 8, 2021
Impact Award Program Announcement
Application Instructions
March 24, 2021
  • The maximum allowable funding for the entire period of performance is $1,250,000 for direct costs.
  • Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.
  • The maximum period of performance is 3 years.
Pre-Application (Preproposal):
May 20, 2021

Application:
September 8, 2021
Translational Team Science Award Program Announcement
Application Instructions
March 24, 2021
  • The maximum allowable funding for the entire period of performance is $2,500,000 for direct costs.
  • Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.
  • The maximum period of performance is 4 years.
Pre-Application (Letter of Intent):
July 29, 2021

Application: August 18, 2021

FY21 Peer Reviewed Medical Research Program (PRMRP)

Mechanism Program Announcement/Instructions Release Date Funding Amount Submission Deadline
Clinical Trial Award Program Announcement
Application Instructions
March 15, 2021 Clinical Trial:
  • Funding limit not defined; requested funding must be appropriate for the scope of work proposed.
  • Maximum period of performance is 4 years for the clinical trial.
Planning Phase with Clinical Trial Option:
  • Maximum of $500,000 for direct costs (plus indirect costs) for the Planning Phase Option.
  • Maximum period of performance is 18 months.
Pre-Application (Preproposal): May 13, 2021

Application: August 26, 2021
Discovery Award Program Announcement
Application Instructions
March 15, 2021
  • Maximum funding of $200,000 for direct costs (plus indirect costs).
  • Maximum period of performance is 2 years.
Pre-Application (Letter of Intent): April 29, 2021

Application: May 13, 2021
Focused Program Award Program Announcement
Application Instructions
March 15, 2021
  • Maximum funding of $7.2 million for direct costs (plus indirect costs).
  • Maximum period of performance is 4 years.
Pre-Application (Preproposal): May 13, 2021

Application: August 26, 2021
Investigator-Initiated Research Award Program Announcement
Application Instructions
March 15, 2021
  • Maximum of $1.6 million for direct costs (plus indirect costs).
  • Maximum of $2.0 million for direct costs (plus indirect costs) for applications including a Partnering PI Option.
  • Maximum period of performance is 4 years.
Pre-Application (Preproposal): April 28, 2021

Application: September 2, 2021
Technology/Therapeutic Development Award Program Announcement
Application Instructions
March 15, 2021 Funding Level 1:
  • Maximum funding of $2 million for direct costs (plus indirect costs).
  • Maximum period of performance is 4 years.
Funding Level 2:
  • Maximum funding of $4 million for direct costs (plus indirect costs).
  • Maximum period of performance is 4 years.
Pre-Application (Preproposal): April 28, 2021

Application: September 2, 2021



FY21 Peer Reviewed Orthopaedic Research Program (PRORP)

Mechanism Program Announcement/Instructions Release Date Funding Amount Submission Deadline
Applied Research Award (ARA) Program Announcement
Application Instructions
April 1, 2021
  • The maximum allowable funding for the entire period of performance is $725,000 for total costs.
  • Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.
  • The maximum period of performance is 3 years.
Pre-Application (Preproposal):
May 27, 2021

Application:
September 10, 2021
Clinical Trial Award (CTA) Program Announcement
Application Instructions
April 1, 2021 Research Level 1:
  • The maximum allowable funding for the entire period of performance is $2.25 million (M) for total costs.
  • Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.
  • The maximum period of performance is 4

Research Level 2:

  • The maximum allowable funding for the entire period of performance is $2.75M for total costs.
  • Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.
  • The maximum period of performance is 4 years.
Pre-Application (Preproposal):
May 27, 2021

Application:
September 10, 2021
Clinical Translational Research Award (CTRA) Program Announcement
Application Instructions
April 1, 2021
  • The maximum allowable funding for the entire period of performance is $1.5M for total costs.
  • Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.
  • The maximum period of performance is 4 years.
Pre-Application (Preproposal):
May 27, 2021

Application:
September 10, 2021


FY21 Prostate Cancer Research Program (PCRP)

Mechanism Program Announcement/Instructions Release Date Funding Amount Submission Deadline
Early Investigator Research Award Program Announcement
Application Instructions
April 5, 2021
  • The maximum allowable funding for the entire period of performance is $300,000 for direct costs.
  • The maximum period of performance is 2 years.
Pre-application (Letter of Intent): June 17, 2021

Confidential Letters of Recommendation: July 7, 2021

Application: July 1, 2021
Physician Research Award Program Announcement
Application Instructions
April 5, 2021
  • The maximum allowable funding for the entire period of performance is $750,000 for direct costs.
  • The maximum period of performance is 4 years.
Pre-application (Letter of Intent): June 17, 2021

Confidential Letters of Recommendation: July 7, 2021

Application: July 1, 2021
Translational Science Award Program Announcement
Application Instructions
April 5, 2021
  • The maximum allowable funding for the entire period of performance is $750,000 for direct costs.
  • The maximum period of performance is 3 years.
Pre-application (Letter of Intent): July 15, 2021

Application: July 29, 2021
Health Disparity Research Award Program Announcement
Application Instructions
April 5, 2021
  • The maximum allowable funding for the entire period of performance is $750,000 for direct costs.
  • The maximum period of performance is 3 years.
Pre-application (Letter of Intent): July 15, 2021

Application: July 29, 2021
Idea Development Award Program Announcement
Application Instructions
April 5, 2021
  • The maximum allowable funding for the entire period of performance is $750,000 for direct costs.
  • The maximum period of performance is 3 years.
Pre-application (Letter of Intent): September 2, 2021

Application: September 23, 2021
Clinical Consortium Award Program Announcement
Application Instructions
April 8, 2021 Coordinating Center:
  • Maximum funding of $7,200,000 for direct costs (plus indirect costs), including no less than $500,000 per year for support of two or more Affiliate Clinical Research Sites.
  • Maximum period of performance is 4 years.

Clinical Sites:

  • Maximum funding of $1,200,000 for direct costs (plus indirect costs).
  • Maximum period of performance is 4 years
Pre-Application (Letter of Intent): September 2, 2021

Application: September 23, 2021
Data Science Award Program Announcement
Application Instructions
April 8, 2021
  • Maximum funding of $1,000,000 for direct costs (plus indirect costs).
  • The maximum period of performance is 3 years.
Pre-Application (Letter of Intent): July 15, 2021

Application: July 29, 2021
Health Equity Research and Outcomes Improvement Consortium (HEROIC) Award Program Announcement
Application Instructions
April 8, 2021 Phase 1:
  • Maximum funding of $2,700,000 for direct costs (plus indirect costs).
  • Maximum period of performance is 2 years.

Phase 2:

  • Maximum funding of $10,000,000 for direct costs (plus indirect costs).
  • Maximum period of performance is 4 years.
Pre-Application (Letter of Intent): July 15, 2021

Application: July 29, 2021


FY21 Spinal Cord Injury Research Program (SCIRP)

Mechanism Program Announcement/Instructions Release Date Funding Amount Submission Deadline
Clinical Trial Award Program Announcement
Application Instructions
March 29, 2021
  • The maximum allowable funding for the entire period of performance is $3 million (M) for direct costs.
  • The maximum period of performance is 4 years.
Pre-Application (Preproposal): May 24, 2021

Application:
September 3, 2021
Translational Research Award Program Announcement
Application Instructions
March 29, 2021
  • The maximum allowable funding for the entire period of performance is $1.25M for direct costs.
  • The maximum period of performance is 3 years.
Pre-Application (Preproposal): May 24, 2021

Application:
September 3, 2021
Investigator-Initiated Research Award Program Announcement
Application Instructions
March 29, 2021
  • The maximum allowable funding for the entire period of performance is $500,000 for direct costs.
  • The maximum period of performance is 3 years.
Pre-Application (Preproposal): May 24, 2021

Application:
September 3, 2021


FY21 Tick-Borne Disease Research Program (TBDRP)

Mechanism Program Announcement/Instructions Release Date Funding Amount Submission Deadline
Career Development Award Program Announcement
Application Instructions
March 22, 2021
  • Maximum funding of $300K for direct costs (plus indirect costs).
  • Maximum period of performance is 3 years.
Pre-Application (Preproposal): May 26, 2021

Preproposal is required; application submission is by invitation only.

Application: August 27, 2021
Idea Development Award Program Announcement
Application Instructions
March 22, 2021
  • Maximum funding of $600K for direct costs (plus indirect costs).
  • Maximum period of performance is 3 years.
Pre-Application (Preproposal): May 26, 2021

Preproposal is required; application submission is by invitation only.

Application: August 27, 2021


FY21 Tuberous Sclerosis Complex Research Program (TSCRP)

Mechanism Program Announcement/Instructions Release Date Funding Amount Submission Deadline
Exploration - Hypothesis Development Award Program Announcement
Application Instructions
April 1, 2021
  • The maximum period of performance is 2 years.
  • The maximum allowable funding for the entire period of performance is $150,000 in direct costs.
  • Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.
Pre-Application (Letter of Intent): June 17, 2021

Application: July 8, 2021
Idea Development Award Program Announcement
Application Instructions
April 1, 2021
  • The maximum period of performance is 3 years.
  • The maximum allowable funding for the entire period of performance is $500,000 in direct costs.
  • Indirect costs may be proposed in accordance with the institution's negotiated rate agreement.
Pre-Application (Letter of Intent): June 17, 2021

Application: July 8, 2021
Clinical Translational Research Award Program Announcement
Application Instructions
April 1, 2021
  • The maximum period of performance is 3 years.
  • The maximum allowable funding for the entire period of performance is $750,000 in direct costs.
  • Indirect costs may be proposed in accordance with the institution's negotiated rate agreement.
Pre-Application (Letter of Intent): June 17, 2021

Application: July 8, 2021

Last updated Wednesday, April 14, 2021